Philips has been awarded the title of “Top 100 Global Innovators” for eleven consecutive years

Recently, Royal Philips of the Netherlands has once again been awarded the title of ClarivateTM's "Top 100 Global Innovation Organizations" for eleven consecutive years by virtue of its industry-leading innovation and innovation scale, and won the title of "Medical and Biotechnology" track in 2024. Top of the list. As a global leader in health technology, Philips continues to invest heavily in innovative research and development and ecological cooperation. With products and services covering the "whole process of health care", it provides strong support for the clinical and scientific research needs of hospitals at all levels and the care of patients inside and outside the hospital. And empower consumers to better manage their health and live a healthier life.

"Philips has more than 130 years of innovation. We always adhere to the concept of 'patient safety and product quality first', carry out innovation and design based on people's needs, continue to create sustainable influence and improve people's health and well-being." Philips Global Chief Executive Officer Executive Officer Jia Borui said, "Innovation is the core competitiveness of Philips. We create differentiated strength through innovation and stand out in the market competition. We are honored that our innovative strength has been widely recognized by all sectors of society and has once again been awarded the 'Global Top 100' Innovation Institution' title. We will continue to focus on 'people-oriented' and 'patient-centered' innovation, and relentlessly promote the development and application of cutting-edge technologies in the industry, so as to better meet the needs of our customers."

With substantial investment in innovation and R&D, Philips' products and services have effectively improved the lives of many people, and steadily contributed to the improvement of quality, efficiency and low-carbon development of the health care system, allowing high-quality medical services to benefit a wide range of people. For example:

Philips magnetic resonance, which uses BlueSeal technology and has the performance advantage of non-liquid helium consumption magnets, has more than a thousand installed machines worldwide, significantly reducing equipment installation and maintenance costs for medical institutions, while reducing dependence on liquid helium supply, which has brought remarkable results Considerable health economic benefits.

Philips' new generation Azurion image-guided treatment system and cutting-edge information platform, recently launched at the European Congress of Radiology (ECR), help improve the quality and efficiency of accurate diagnosis and interventional treatment.

In the future, Philips will continue to move forward with honor and rely on its strong innovation in the field of health technology to work with all parties to build a more resilient and sustainable health care system to improve the health and well-being of more people.